Experience in treating two hundred and eighty-eight patients with endometrial carcinoma from 1968 to 1972.
The results in treatment of 288 patients with endometrial carcinoma (1968 to 1972) were compared to results achieved in a similar series of 236 patients (1962 to 1967) at The University of Alberta, Edmonton, Alberta, Canada. The overall 5 year survival rate for the 524 patients was 76.1% (75.4% when Stage 0 is excluded), with generally better results in the more recent series except in treating Stage II disease. The overall 5 year survival rate for Stage I disease in the more recent series was 89.1%. Parameters for assessing a prognosis and management plan are indicated, with emphasis on the identification of high-risk Stage I cases.